In this study, we have observed the upregulation of GPX1 and 2 protein expression, increased GPX enzyme activity, and decreased intracellular ROS in response to Ets-1 overexpression in ovarian cancer cells. The gene discussed is ETS1; the disease is ovarian carcinoma.